Nob - Model DryNeb - Dry Powder Nebulizer
The DryNeb dry powder nebulizer is a patented technology that can deliver drugs to the lower respiratory tract with much higher efficiency than current state of the art dry powder inhalers.
-
Most popular related searches
Products Details
DryNeb can deliver high dose, pure active ingredient, with rapid targeted delivery, and is being developed as a platform technology. Performance is unmatched by any known commercial or in-development dry powder inhaler and clearly differentiates the technology. Our technology has several key technological innovations compared to standard dry powder inhalers in generating highly efficient drug aerosols and delivering them effectively to the lower respiratory tract, independent of the patient’s lung capacity. DryNeb disperses the powder independently from the patient’s inhalation force, ensuring reproducible delivery no matter the lung function of the patient, and it is designed to emit powder from the device only when a patient inhales, thus no coordination is required.
Applications
DryNeb Dry Powder Nebulizer is initially being targeted at LRI therapies for which there is a large unmet need: viral infections, fungal infections, bacterial infections of lung.
The Platform technology is also be able to deliver drugs that treat lung cancer and other deadly lung diseases. The targeted delivery will minimize drug side effects/toxicities and provide high concentrations of drug to the site of disease/infection.
The company has recently successfully achieved several key milestones as part of an early assessment of an inhaled anti-fungal agent through an NIH SBIR Phase I award and is now seeking funding to commence the clinical development program of this important therapeutic. In addition, in-vitro evaluations are being conducted to establish other potential clinical applications of the DryNeb.
Customer reviews
No reviews were found for Nob - Model DryNeb - Dry Powder Nebulizer. Be the first to review!